EIF2AK3 and type 1 diabetes mellitus: Immunohistochemistry (IHC) staining of pancreas sections from T1D patients revealed PERK pathway activation in insulin-secreting beta cells, relative to healthy control patient samples [13], and PERK activation precedes the destructive autoimmune attack of beta cells in animal models of T1D [12,14].